ArticleJournal of clinical and experimental hepatology

Lenvatinib Maintenance Therapy After Complete Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: Alternative Strategy in a Resource-limited Setting.

Pramod Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.